journal article Mar 01, 1996

Cystic fibrosis-an Indian perspective on recent advances in diagnosis and management

View at Publisher Save 10.1007/bf02845243
Topics

No keywords indexed for this article. Browse by subject →

References
49
[1]
Wood RE. Treatment of CF lung disease in first two years.Pediatr Pulmonol 1989; 4: 68–70.
[2]
Fitz Simmons S. The changing epidemiology of cystic fibrosis.J Pediatr 1993; 122: 1–9. 10.1016/s0022-3476(05)83478-x
[3]
Goodchild MC, Insley J, Ruston DI, Gaze H. Cystic fibrosis in three Pakistani children.Arch Dis Child 1974; 49: 739–741. 10.1136/adc.49.9.739
[4]
Spencer DA, Venkataraman M, Higgin S et al. Cystic fibrosis in the children from ethnic minorites in the West Midlands.Respiratory Medicine 1994; 88: 671–675. 10.1016/s0954-6111(05)80065-4
[5]
Maya PP, Hill PG, Sundaram D, Jadhav M. Cystic fibrosis in South India.Trop Geogr Med 1980; 32: 45–49.
[6]
Reddy CR, Sita Devi C, Anees AMet al. Cystic fibrosis of pancreas in India.J Trop Med Hyg 1970; 73: 56–62.
[7]
Mehta S, Wadhwa UN, Mehta SK, Chhuttani PN. Fibrocystic disease of pancreas in India.Indian Peditr 1968; 5: 185–191.
[8]
Kerem B, Rommens JM, Buchanan JAet al. Identification of the cystic fibrosis gene. Genetic analysis.Science 1989; 245: 1073–1080. 10.1126/science.2570460
[9]
Riordan JR, Rommens JM, Kerem Bet al. Identification of the cystic fibrosis gene: cloning and characterization of comple-mentary DNA.Science 1989; 245: 1066–1073. 10.1126/science.2475911
[10]
Tsui LC. The spectrum of cystic fibrosis mutations.Trends Genet 1992; 8: 392–398. 10.1016/0168-9525(92)90301-j
[11]
The Cystic fibrosis Genetic Consortium. Population variation of common cystic fibrosis mutations.Human Mutation 1994; 4: 167–177. 10.1002/humu.1380040302
[12]
Frizzell RA. Functions of the cystic fibrosis transmembrane conductance regulatory protein.Am J Respir Crit Care Med 1995; 151: S54-S58. 10.1164/ajrccm/151.3_pt_2.s54
[13]
Maclusky I, Levison H. Cystic Fibrosis in Kendig's Disorders of the Respiratory Tract in Children. Cherck OV and Kendig EL, eds. WB Saunders company. 1990, Philadelphia V ed, pp 692–730.
[14]
Stern RC, Boat TF, Doershuk CF. Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome.Lancet 1982; 198: 1401–1403. 10.1016/s0140-6736(82)92512-0
[15]
Schales O, Schales SS. A simple and accurate method for the determination of chloride in biological fluid.J Biol Chem 1941; 140: 879–884. 10.1016/s0021-9258(18)72872-x
[16]
Hammond KB, Turcios NL, Gibson LE. Clinical evaluation of the macroduct sweat collection system and conductivity analyser in the diagnosis of cystic fibrosis.J Pediatr 1994; 124: 255–260. 10.1016/s0022-3476(94)70314-0
[17]
Verlinksy Y, Reshitsky S, Evsikov Set al. Preconception and preimplantation diagnosis for cystic fibrosis.Prenat Diagn 1992; 12: 103–106. 10.1002/pd.1970120205
[18]
Brambati B, Tului L, Fettore S. First trimester fetal screening of cystic fibrosis in low risk population.Lancet 1993; 342: 624–626. 10.1016/0140-6736(93)91456-v
[19]
Black SH, Bick DP, Maddalena Aet al. Pregnancy screening for cystic fibrosis.Lancet 1993; 342: 1112–1115. 10.1016/0140-6736(93)92093-9
[20]
Phelan PD, Neonatal screening for cystic fibrosis.Thorax 1995; 50: 705–706. 10.1136/thx.50.7.705
[21]
Danker Roelse JE, Meerman GJ. Long term prognoss of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre.Thaorax 1995; 50: 712–718. 10.1136/thx.50.7.712
[22]
Crossley JR, Elliot RB, Smith PA. Dried bloodspot screening for cystic fibrosis in the newborn.Lancet 1979; 1: 472. 10.1016/s0140-6736(79)90825-0
[23]
Desmond KJ, Schwenk WF, Thomas Eet al. Immediate and longterm effects of chest physiotherapy in patients with cystic fibrosis.J Pediatr 1983; 103: 538–542. 10.1016/s0022-3476(83)80579-4
[24]
Verboon JML, Baker W, Sterk PJ. The value of the forced expiration technique with and without postural drainage in adults with cystic fibrosis.Eur J Resp Dis 1986; 69: 169–175.
[25]
Hofmeyr JL, Weber BA, Hodson ME. Evaluation of positive expiratory pressure on an adjunct to chest physiotherapy in the treatment of cystic fibrosis.Thorax 1986; 41: 951–956. 10.1136/thx.41.12.951
[26]
Blomquist M, Frwy Schuss U, Wiman LGet al. Physical activity and self treatment in cystic fibrosis.Arch Dis Child 1986; 61: 362–368. 10.1136/adc.61.4.362
[27]
Millers S, Hall DO, Clyton CB, Nelson R. Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainaige and the active cycle of breathing techniques with postural drainaige.Thorax 1995; 50: 165–169. 10.1136/thx.50.2.165
[28]
Ratjen F, Wonne R, Posselt HGet al. A double blind placebo controlled trial with oral ambroxol and N acetyl cysteine for mucolytic treatment in cystic fibrosis.Eur J Pediatr 1985; 144: 374–380. 10.1007/bf00441781
[29]
Hodson ME. Aerosolized Dornase Alfa (rhDNase) for therapy of cystic fibrosis.Am J Resp Crit Care Med 1995; 151: 570–574. 10.1164/ajrccm/151.3_pt_2.s70
[30]
Wilmott RW, Fiedler MA. Recent advances in the treatment of cystic fibrosis.Ped Clin North Am 1994; 41: 431–451. 10.1016/s0031-3955(16)38764-8
[31]
Raeburn JA, Govan JRW, McCrae WMet al. Ciprofloxacin therapy in cystic fibrosis. J Antimicrob Chemotherapy 1987; 20: 195–302. 10.1093/jac/20.3.295
[32]
Rubio TT. Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.Dign Microbiol Infect Dis 1990; 13: 153–155. 10.1016/0732-8893(90)90099-h
[33]
Ramsey BW, Dorkin HL, Eisenberg JPet al. Efficacy of aerosolized tobramicin in patients with cystic fibrosis.N Engl J Med 1993; 328: 17740–1746. 10.1056/nejm199306173282403
[34]
Hodson ME, Penkoth ARL, Batten JC. Aerosol carbenicillin and gentamicin treatment of pseudomonas aeruginosa infection in patients with cystic fibrosis.Lancet 1981; 2: 1137–1141. 10.1016/s0140-6736(81)90588-2
[35]
Eber E, Oberwaldner B, Zach MS. Airway obstruction and airway wall instability in cystic fibrosis.Pediatr Pulmonol 1988; 4: 205–209. 10.1002/ppul.1950040404
[36]
Green MR, Buchanan E, Weaver LT. Nutritional management of the infants with cystic fibrosis.Arch dis Child 1995; 72: 452–456. 10.1136/adc.72.5.452
[37]
Shephered RW, Holt TL, Thomas BJet al. Nutritional rehailitation in cystic fibrosis controlled studies of effects on nutritional growth retardation, body protein turnover-and course of pulmonary disease.J Pediatr 1986; 109: 788–792. 10.1016/s0022-3476(86)80695-3
[38]
Boland MP, Stoski DS, Mcdonald NE, Soucy P. Chronic jejunostomy feeding with a nonelemental formula in undernourished patients with cystic fibrosis.Lancet 1986; 1: 232–236. 10.1016/s0140-6736(86)90772-5
[39]
Mansell AL, Anderson JC, Muttort CRet al. Short term pulmonary effects of total parenteral nutrition in children with cystic fibrosis.J Pediatr 1984; 104: 700–706. 10.1016/s0022-3476(84)80947-6
[40]
Kelleter J, Laboratory measurement of nutrition in cystic fibrosis.J R Soc Med 1987; 25: 80, 25–32.
[41]
Long-Term Study of One Hundred Five Patients with Cystic Fibrosis

HARRY SHWACHMAN

A.M.A. Journal of Diseases of Children 1958 10.1001/archpedi.1958.02060060008002
[42]
Lewiston N, Moss R. Inter observer variance in clinical scoring for cystic fibrosis.Chest 1987; 91: 878–882. 10.1378/chest.91.6.878
[43]
Hansell D, Stricklan B. High resolution computer tomography in pulmonary cystic fibrosis.Br J Radiol 1989; 62: 1–5. 10.1259/0007-1285-62-733-1
[44]
Mc Elavncy NG, Hubbard RC, Birrer Pet al. Aerosol alfa-1-anti-trypsin treatment for cystic fibrosis.Lancet 1991; 337: 392–394. 10.1016/0140-6736(91)91167-s
[45]
Mc Elavncy NG, Nakamura H, Birrer Pet al. Modulation of airway inflamation in cystic fibrosis. In vivo supression of interleukin B levels on the respiratory epithelial surface by aerosolization of recominant secretory leukoprotease inhibitor.J Clin Invest 1992; 90: 1296–1301. 10.1172/jci115994
[46]
Krost RJ, McElvancy NG, Chu Cet al. Gene therapy for the respiratory manifestations of cystic fibrosis.Aam J Respir Crit Care Med 1995; 151: 575–587.
[47]
Smyth RL, Higenbottam T, Scott Jet al. Cystic fibrosis: the current state of lung transplantations for cystic fibrosis.Thorax 1991; 46: 213–216. 10.1136/thx.46.3.213
[48]
Pasque MK, Cooper JD, Kaiser LRet al. Improved technique for bilateral lung transplantation; rationale and initial clinical experience.Ann Thorac Surg 1990; 49: 785–791. 10.1016/0003-4975(90)90023-y
[49]
Knowles MR, Church NL, Waltner WEet al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.N Eng J Med 1990; 322: 1189–1194. 10.1056/nejm199004263221704
Cited By
7
The Indian Journal of Pediatrics
Metrics
7
Citations
49
References
Details
Published
Mar 01, 1996
Vol/Issue
63(2)
Pages
189-198
License
View
Cite This Article
S. K. Kabra, Madhulika Kabra, M. Ghosh, et al. (1996). Cystic fibrosis-an Indian perspective on recent advances in diagnosis and management. The Indian Journal of Pediatrics, 63(2), 189-198. https://doi.org/10.1007/bf02845243
Related

You May Also Like

A Review of Coronavirus Disease-2019 (COVID-19)

Tanu Singhal · 2020

2,395 citations

Cerebral palsy-definition, classification, etiology and early diagnosis

Chitra Sankar, Nandini Mundkur · 2005

168 citations

Leukemias in Children

Rachna Seth, Amitabh Singh · 2015

97 citations